 | • レポートコード：MRCLP3DB5425 • 出版社/出版日：LP Information / 2023年12月 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥527,040 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,054,080 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| LPインフォメーション社の最新調査レポート「医薬品用スガマデクスナトリウムの世界市場」は、過去の販売実績から2022年の世界の医薬品用スガマデクスナトリウムの総販売量を検討し、2023年から2029年の予測される医薬品用スガマデクスナトリウムの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医薬品用スガマデクスナトリウムの市場規模を掲載し、XXX百万米ドル規模の世界の医薬品用スガマデクスナトリウム市場の詳細な分析を提供します。本インサイトレポートは、世界の医薬品用スガマデクスナトリウム業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本資料では、加速する世界の医薬品用スガマデクスナトリウム市場における各社の独自のポジションをより深く理解するために、医薬品用スガマデクスナトリウム製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界の医薬品用スガマデクスナトリウム市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医薬品用スガマデクスナトリウムの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医薬品用スガマデクスナトリウムの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医薬品用スガマデクスナトリウムの欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 医薬品用スガマデクスナトリウムの世界主要メーカーとしては、BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD、 LEK PHARMACEUTICALS DD、 MSN LIFE SCIENCES PRIVATE LTD、 DR REDDYS LABORATORIES LTD、 MYLAN LABORATORIES LTD、 ASOLUTION PHARMACEUTICALS PVT LTD、 EXTROVIS AG、 WAVELENGTH ENTERPRISES LTD、 FARMHISPANIA SA、 SOLARA ACTIVE PHARMA SCIENCES LTD、 GLAND PHARMA LTD、 SCINOPHARM TAIWAN LTD、 BIOPHORE INDIA PHARMACEUTICALS PVT LTD、 HONOUR LAB LTD、 USV PRIVATE LTD、 AUROBINDO PHARMA LTD、 NEULAND LABORATORIES LTD、 MANKIND PHARMA LTD、 NATCO PHARMA LTD、 TEVA PHARMACEUTICAL INDUSTRIES LTD、 MEDICHEM MANUFACTURING MALTA LTD、 FRESENIUS KABI ONCOLOGY LTD、 RUYUAN HEC PHARM CO LTD、 HEFEI BOSIKC PHARMTECH CO LTD、 CHANGZHOU PHARMACEUTICAL FACTORY、 ZHEJIANG AUSUN PHARMACEUTICAL CO LTDなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別の医薬品用スガマデクスナトリウム市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 本調査では医薬品用スガマデクスナトリウム市場をセグメンテーションし、種類別 (純度≧99%、純度<99%)、用途別 (注射剤、その他)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：純度≧99%、純度<99% ・用途別区分：注射剤、その他 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界の医薬品用スガマデクスナトリウム市場の10年間の市場状況・展望は？ ・世界および地域別に見た医薬品用スガマデクスナトリウム市場成長の要因は何か？ ・医薬品用スガマデクスナトリウムの市場機会はエンドマーケットの規模によってどのように変化するのか？ ・医薬品用スガマデクスナトリウムのタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：医薬品用スガマデクスナトリウムの年間販売量2018-2029、地域別現状・将来分析 ・医薬品用スガマデクスナトリウムの種類別セグメント：純度≧99%、純度<99% ・医薬品用スガマデクスナトリウムの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・医薬品用スガマデクスナトリウムの用途別セグメント：注射剤、その他 ・医薬品用スガマデクスナトリウムの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界の医薬品用スガマデクスナトリウム市場 ・企業別のグローバル医薬品用スガマデクスナトリウム市場データ：2018-2023年の年間販売量、市場シェア ・企業別の医薬品用スガマデクスナトリウムの年間売上：2018-2023年の売上、市場シェア ・企業別の医薬品用スガマデクスナトリウム販売価格 ・主要企業の医薬品用スガマデクスナトリウム生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 医薬品用スガマデクスナトリウムの地域別レビュー ・地域別の医薬品用スガマデクスナトリウム市場規模2018-2023：年間販売量、売上 ・主要国別の医薬品用スガマデクスナトリウム市場規模2018-2023：年間販売量、売上 ・南北アメリカの医薬品用スガマデクスナトリウム販売の成長 ・アジア太平洋の医薬品用スガマデクスナトリウム販売の成長 ・欧州の医薬品用スガマデクスナトリウム販売の成長 ・中東・アフリカの医薬品用スガマデクスナトリウム販売の成長 南北アメリカ市場 ・南北アメリカの国別の医薬品用スガマデクスナトリウム販売量、売上（2018-2023） ・南北アメリカの医薬品用スガマデクスナトリウムの種類別販売量 ・南北アメリカの医薬品用スガマデクスナトリウムの用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別の医薬品用スガマデクスナトリウム販売量、売上（2018-2023） ・アジア太平洋の医薬品用スガマデクスナトリウムの種類別販売量 ・アジア太平洋の医薬品用スガマデクスナトリウムの用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 欧州市場 ・欧州の国別の医薬品用スガマデクスナトリウム販売量、売上（2018-2023） ・欧州の医薬品用スガマデクスナトリウムの種類別販売量 ・欧州の医薬品用スガマデクスナトリウムの用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別の医薬品用スガマデクスナトリウム販売量、売上（2018-2023） ・中東・アフリカの医薬品用スガマデクスナトリウムの種類別販売量 ・中東・アフリカの医薬品用スガマデクスナトリウムの用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・医薬品用スガマデクスナトリウムの製造コスト構造分析 ・医薬品用スガマデクスナトリウムの製造プロセス分析 ・医薬品用スガマデクスナトリウムの産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・医薬品用スガマデクスナトリウムの主要なグローバル販売業者 ・医薬品用スガマデクスナトリウムの主要なグローバル顧客 地域別の医薬品用スガマデクスナトリウム市場予測レビュー ・地域別の医薬品用スガマデクスナトリウム市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・医薬品用スガマデクスナトリウムの種類別市場規模予測 ・医薬品用スガマデクスナトリウムの用途別市場規模予測 主要企業分析 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD、 LEK PHARMACEUTICALS DD、 MSN LIFE SCIENCES PRIVATE LTD、 DR REDDYS LABORATORIES LTD、 MYLAN LABORATORIES LTD、 ASOLUTION PHARMACEUTICALS PVT LTD、 EXTROVIS AG、 WAVELENGTH ENTERPRISES LTD、 FARMHISPANIA SA、 SOLARA ACTIVE PHARMA SCIENCES LTD、 GLAND PHARMA LTD、 SCINOPHARM TAIWAN LTD、 BIOPHORE INDIA PHARMACEUTICALS PVT LTD、 HONOUR LAB LTD、 USV PRIVATE LTD、 AUROBINDO PHARMA LTD、 NEULAND LABORATORIES LTD、 MANKIND PHARMA LTD、 NATCO PHARMA LTD、 TEVA PHARMACEUTICAL INDUSTRIES LTD、 MEDICHEM MANUFACTURING MALTA LTD、 FRESENIUS KABI ONCOLOGY LTD、 RUYUAN HEC PHARM CO LTD、 HEFEI BOSIKC PHARMTECH CO LTD、 CHANGZHOU PHARMACEUTICAL FACTORY、 ZHEJIANG AUSUN PHARMACEUTICAL CO LTD ・企業情報 ・医薬品用スガマデクスナトリウム製品 ・医薬品用スガマデクスナトリウム販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
The global Pharmaceutical Grade Sugammadex Sodium market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceutical Grade Sugammadex Sodium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Grade Sugammadex Sodium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Grade Sugammadex Sodium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Grade Sugammadex Sodium players cover BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD, LEK PHARMACEUTICALS DD, MSN LIFE SCIENCES PRIVATE LTD, DR REDDYS LABORATORIES LTD, MYLAN LABORATORIES LTD, ASOLUTION PHARMACEUTICALS PVT LTD, EXTROVIS AG, WAVELENGTH ENTERPRISES LTD and FARMHISPANIA SA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Pharmaceutical Grade Sugammadex Sodium Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Sugammadex Sodium sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Sugammadex Sodium sales for 2023 through 2029. With Pharmaceutical Grade Sugammadex Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Sugammadex Sodium industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Sugammadex Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Sugammadex Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Sugammadex Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Sugammadex Sodium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Sugammadex Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Sugammadex Sodium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Purity≥99%
Purity<99%
Segmentation by application
Injection
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD
LEK PHARMACEUTICALS DD
MSN LIFE SCIENCES PRIVATE LTD
DR REDDYS LABORATORIES LTD
MYLAN LABORATORIES LTD
ASOLUTION PHARMACEUTICALS PVT LTD
EXTROVIS AG
WAVELENGTH ENTERPRISES LTD
FARMHISPANIA SA
SOLARA ACTIVE PHARMA SCIENCES LTD
GLAND PHARMA LTD
SCINOPHARM TAIWAN LTD
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
HONOUR LAB LTD
USV PRIVATE LTD
AUROBINDO PHARMA LTD
NEULAND LABORATORIES LTD
MANKIND PHARMA LTD
NATCO PHARMA LTD
TEVA PHARMACEUTICAL INDUSTRIES LTD
MEDICHEM MANUFACTURING MALTA LTD
FRESENIUS KABI ONCOLOGY LTD
RUYUAN HEC PHARM CO LTD
HEFEI BOSIKC PHARMTECH CO LTD
CHANGZHOU PHARMACEUTICAL FACTORY
ZHEJIANG AUSUN PHARMACEUTICAL CO LTD
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade Sugammadex Sodium market?
What factors are driving Pharmaceutical Grade Sugammadex Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Sugammadex Sodium market opportunities vary by end market size?
How does Pharmaceutical Grade Sugammadex Sodium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Grade Sugammadex Sodium Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pharmaceutical Grade Sugammadex Sodium by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pharmaceutical Grade Sugammadex Sodium by Country/Region, 2018, 2022 & 2029
2.2 Pharmaceutical Grade Sugammadex Sodium Segment by Type
2.2.1 Purity≥99%
2.2.2 Purity<99%
2.3 Pharmaceutical Grade Sugammadex Sodium Sales by Type
2.3.1 Global Pharmaceutical Grade Sugammadex Sodium Sales Market Share by Type (2018-2023)
2.3.2 Global Pharmaceutical Grade Sugammadex Sodium Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pharmaceutical Grade Sugammadex Sodium Sale Price by Type (2018-2023)
2.4 Pharmaceutical Grade Sugammadex Sodium Segment by Application
2.4.1 Injection
2.4.2 Others
2.5 Pharmaceutical Grade Sugammadex Sodium Sales by Application
2.5.1 Global Pharmaceutical Grade Sugammadex Sodium Sale Market Share by Application (2018-2023)
2.5.2 Global Pharmaceutical Grade Sugammadex Sodium Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pharmaceutical Grade Sugammadex Sodium Sale Price by Application (2018-2023)
3 Global Pharmaceutical Grade Sugammadex Sodium by Company
3.1 Global Pharmaceutical Grade Sugammadex Sodium Breakdown Data by Company
3.1.1 Global Pharmaceutical Grade Sugammadex Sodium Annual Sales by Company (2018-2023)
3.1.2 Global Pharmaceutical Grade Sugammadex Sodium Sales Market Share by Company (2018-2023)
3.2 Global Pharmaceutical Grade Sugammadex Sodium Annual Revenue by Company (2018-2023)
3.2.1 Global Pharmaceutical Grade Sugammadex Sodium Revenue by Company (2018-2023)
3.2.2 Global Pharmaceutical Grade Sugammadex Sodium Revenue Market Share by Company (2018-2023)
3.3 Global Pharmaceutical Grade Sugammadex Sodium Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Grade Sugammadex Sodium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Grade Sugammadex Sodium Product Location Distribution
3.4.2 Players Pharmaceutical Grade Sugammadex Sodium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceutical Grade Sugammadex Sodium by Geographic Region
4.1 World Historic Pharmaceutical Grade Sugammadex Sodium Market Size by Geographic Region (2018-2023)
4.1.1 Global Pharmaceutical Grade Sugammadex Sodium Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pharmaceutical Grade Sugammadex Sodium Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pharmaceutical Grade Sugammadex Sodium Market Size by Country/Region (2018-2023)
4.2.1 Global Pharmaceutical Grade Sugammadex Sodium Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pharmaceutical Grade Sugammadex Sodium Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pharmaceutical Grade Sugammadex Sodium Sales Growth
4.4 APAC Pharmaceutical Grade Sugammadex Sodium Sales Growth
4.5 Europe Pharmaceutical Grade Sugammadex Sodium Sales Growth
4.6 Middle East & Africa Pharmaceutical Grade Sugammadex Sodium Sales Growth
5 Americas
5.1 Americas Pharmaceutical Grade Sugammadex Sodium Sales by Country
5.1.1 Americas Pharmaceutical Grade Sugammadex Sodium Sales by Country (2018-2023)
5.1.2 Americas Pharmaceutical Grade Sugammadex Sodium Revenue by Country (2018-2023)
5.2 Americas Pharmaceutical Grade Sugammadex Sodium Sales by Type
5.3 Americas Pharmaceutical Grade Sugammadex Sodium Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Grade Sugammadex Sodium Sales by Region
6.1.1 APAC Pharmaceutical Grade Sugammadex Sodium Sales by Region (2018-2023)
6.1.2 APAC Pharmaceutical Grade Sugammadex Sodium Revenue by Region (2018-2023)
6.2 APAC Pharmaceutical Grade Sugammadex Sodium Sales by Type
6.3 APAC Pharmaceutical Grade Sugammadex Sodium Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Grade Sugammadex Sodium by Country
7.1.1 Europe Pharmaceutical Grade Sugammadex Sodium Sales by Country (2018-2023)
7.1.2 Europe Pharmaceutical Grade Sugammadex Sodium Revenue by Country (2018-2023)
7.2 Europe Pharmaceutical Grade Sugammadex Sodium Sales by Type
7.3 Europe Pharmaceutical Grade Sugammadex Sodium Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Grade Sugammadex Sodium by Country
8.1.1 Middle East & Africa Pharmaceutical Grade Sugammadex Sodium Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pharmaceutical Grade Sugammadex Sodium Revenue by Country (2018-2023)
8.2 Middle East & Africa Pharmaceutical Grade Sugammadex Sodium Sales by Type
8.3 Middle East & Africa Pharmaceutical Grade Sugammadex Sodium Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Sugammadex Sodium
10.3 Manufacturing Process Analysis of Pharmaceutical Grade Sugammadex Sodium
10.4 Industry Chain Structure of Pharmaceutical Grade Sugammadex Sodium
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Grade Sugammadex Sodium Distributors
11.3 Pharmaceutical Grade Sugammadex Sodium Customer
12 World Forecast Review for Pharmaceutical Grade Sugammadex Sodium by Geographic Region
12.1 Global Pharmaceutical Grade Sugammadex Sodium Market Size Forecast by Region
12.1.1 Global Pharmaceutical Grade Sugammadex Sodium Forecast by Region (2024-2029)
12.1.2 Global Pharmaceutical Grade Sugammadex Sodium Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Grade Sugammadex Sodium Forecast by Type
12.7 Global Pharmaceutical Grade Sugammadex Sodium Forecast by Application
13 Key Players Analysis
13.1 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD
13.1.1 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Company Information
13.1.2 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.1.3 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Main Business Overview
13.1.5 BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTD Latest Developments
13.2 LEK PHARMACEUTICALS DD
13.2.1 LEK PHARMACEUTICALS DD Company Information
13.2.2 LEK PHARMACEUTICALS DD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.2.3 LEK PHARMACEUTICALS DD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 LEK PHARMACEUTICALS DD Main Business Overview
13.2.5 LEK PHARMACEUTICALS DD Latest Developments
13.3 MSN LIFE SCIENCES PRIVATE LTD
13.3.1 MSN LIFE SCIENCES PRIVATE LTD Company Information
13.3.2 MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.3.3 MSN LIFE SCIENCES PRIVATE LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 MSN LIFE SCIENCES PRIVATE LTD Main Business Overview
13.3.5 MSN LIFE SCIENCES PRIVATE LTD Latest Developments
13.4 DR REDDYS LABORATORIES LTD
13.4.1 DR REDDYS LABORATORIES LTD Company Information
13.4.2 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.4.3 DR REDDYS LABORATORIES LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 DR REDDYS LABORATORIES LTD Main Business Overview
13.4.5 DR REDDYS LABORATORIES LTD Latest Developments
13.5 MYLAN LABORATORIES LTD
13.5.1 MYLAN LABORATORIES LTD Company Information
13.5.2 MYLAN LABORATORIES LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.5.3 MYLAN LABORATORIES LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 MYLAN LABORATORIES LTD Main Business Overview
13.5.5 MYLAN LABORATORIES LTD Latest Developments
13.6 ASOLUTION PHARMACEUTICALS PVT LTD
13.6.1 ASOLUTION PHARMACEUTICALS PVT LTD Company Information
13.6.2 ASOLUTION PHARMACEUTICALS PVT LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.6.3 ASOLUTION PHARMACEUTICALS PVT LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 ASOLUTION PHARMACEUTICALS PVT LTD Main Business Overview
13.6.5 ASOLUTION PHARMACEUTICALS PVT LTD Latest Developments
13.7 EXTROVIS AG
13.7.1 EXTROVIS AG Company Information
13.7.2 EXTROVIS AG Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.7.3 EXTROVIS AG Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 EXTROVIS AG Main Business Overview
13.7.5 EXTROVIS AG Latest Developments
13.8 WAVELENGTH ENTERPRISES LTD
13.8.1 WAVELENGTH ENTERPRISES LTD Company Information
13.8.2 WAVELENGTH ENTERPRISES LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.8.3 WAVELENGTH ENTERPRISES LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 WAVELENGTH ENTERPRISES LTD Main Business Overview
13.8.5 WAVELENGTH ENTERPRISES LTD Latest Developments
13.9 FARMHISPANIA SA
13.9.1 FARMHISPANIA SA Company Information
13.9.2 FARMHISPANIA SA Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.9.3 FARMHISPANIA SA Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 FARMHISPANIA SA Main Business Overview
13.9.5 FARMHISPANIA SA Latest Developments
13.10 SOLARA ACTIVE PHARMA SCIENCES LTD
13.10.1 SOLARA ACTIVE PHARMA SCIENCES LTD Company Information
13.10.2 SOLARA ACTIVE PHARMA SCIENCES LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.10.3 SOLARA ACTIVE PHARMA SCIENCES LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 SOLARA ACTIVE PHARMA SCIENCES LTD Main Business Overview
13.10.5 SOLARA ACTIVE PHARMA SCIENCES LTD Latest Developments
13.11 GLAND PHARMA LTD
13.11.1 GLAND PHARMA LTD Company Information
13.11.2 GLAND PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.11.3 GLAND PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 GLAND PHARMA LTD Main Business Overview
13.11.5 GLAND PHARMA LTD Latest Developments
13.12 SCINOPHARM TAIWAN LTD
13.12.1 SCINOPHARM TAIWAN LTD Company Information
13.12.2 SCINOPHARM TAIWAN LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.12.3 SCINOPHARM TAIWAN LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 SCINOPHARM TAIWAN LTD Main Business Overview
13.12.5 SCINOPHARM TAIWAN LTD Latest Developments
13.13 BIOPHORE INDIA PHARMACEUTICALS PVT LTD
13.13.1 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Company Information
13.13.2 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.13.3 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Main Business Overview
13.13.5 BIOPHORE INDIA PHARMACEUTICALS PVT LTD Latest Developments
13.14 HONOUR LAB LTD
13.14.1 HONOUR LAB LTD Company Information
13.14.2 HONOUR LAB LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.14.3 HONOUR LAB LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 HONOUR LAB LTD Main Business Overview
13.14.5 HONOUR LAB LTD Latest Developments
13.15 USV PRIVATE LTD
13.15.1 USV PRIVATE LTD Company Information
13.15.2 USV PRIVATE LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.15.3 USV PRIVATE LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 USV PRIVATE LTD Main Business Overview
13.15.5 USV PRIVATE LTD Latest Developments
13.16 AUROBINDO PHARMA LTD
13.16.1 AUROBINDO PHARMA LTD Company Information
13.16.2 AUROBINDO PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.16.3 AUROBINDO PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 AUROBINDO PHARMA LTD Main Business Overview
13.16.5 AUROBINDO PHARMA LTD Latest Developments
13.17 NEULAND LABORATORIES LTD
13.17.1 NEULAND LABORATORIES LTD Company Information
13.17.2 NEULAND LABORATORIES LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.17.3 NEULAND LABORATORIES LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 NEULAND LABORATORIES LTD Main Business Overview
13.17.5 NEULAND LABORATORIES LTD Latest Developments
13.18 MANKIND PHARMA LTD
13.18.1 MANKIND PHARMA LTD Company Information
13.18.2 MANKIND PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.18.3 MANKIND PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 MANKIND PHARMA LTD Main Business Overview
13.18.5 MANKIND PHARMA LTD Latest Developments
13.19 NATCO PHARMA LTD
13.19.1 NATCO PHARMA LTD Company Information
13.19.2 NATCO PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.19.3 NATCO PHARMA LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 NATCO PHARMA LTD Main Business Overview
13.19.5 NATCO PHARMA LTD Latest Developments
13.20 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.20.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Company Information
13.20.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.20.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Main Business Overview
13.20.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Latest Developments
13.21 MEDICHEM MANUFACTURING MALTA LTD
13.21.1 MEDICHEM MANUFACTURING MALTA LTD Company Information
13.21.2 MEDICHEM MANUFACTURING MALTA LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.21.3 MEDICHEM MANUFACTURING MALTA LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 MEDICHEM MANUFACTURING MALTA LTD Main Business Overview
13.21.5 MEDICHEM MANUFACTURING MALTA LTD Latest Developments
13.22 FRESENIUS KABI ONCOLOGY LTD
13.22.1 FRESENIUS KABI ONCOLOGY LTD Company Information
13.22.2 FRESENIUS KABI ONCOLOGY LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.22.3 FRESENIUS KABI ONCOLOGY LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 FRESENIUS KABI ONCOLOGY LTD Main Business Overview
13.22.5 FRESENIUS KABI ONCOLOGY LTD Latest Developments
13.23 RUYUAN HEC PHARM CO LTD
13.23.1 RUYUAN HEC PHARM CO LTD Company Information
13.23.2 RUYUAN HEC PHARM CO LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.23.3 RUYUAN HEC PHARM CO LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 RUYUAN HEC PHARM CO LTD Main Business Overview
13.23.5 RUYUAN HEC PHARM CO LTD Latest Developments
13.24 HEFEI BOSIKC PHARMTECH CO LTD
13.24.1 HEFEI BOSIKC PHARMTECH CO LTD Company Information
13.24.2 HEFEI BOSIKC PHARMTECH CO LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.24.3 HEFEI BOSIKC PHARMTECH CO LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 HEFEI BOSIKC PHARMTECH CO LTD Main Business Overview
13.24.5 HEFEI BOSIKC PHARMTECH CO LTD Latest Developments
13.25 CHANGZHOU PHARMACEUTICAL FACTORY
13.25.1 CHANGZHOU PHARMACEUTICAL FACTORY Company Information
13.25.2 CHANGZHOU PHARMACEUTICAL FACTORY Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.25.3 CHANGZHOU PHARMACEUTICAL FACTORY Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 CHANGZHOU PHARMACEUTICAL FACTORY Main Business Overview
13.25.5 CHANGZHOU PHARMACEUTICAL FACTORY Latest Developments
13.26 ZHEJIANG AUSUN PHARMACEUTICAL CO LTD
13.26.1 ZHEJIANG AUSUN PHARMACEUTICAL CO LTD Company Information
13.26.2 ZHEJIANG AUSUN PHARMACEUTICAL CO LTD Pharmaceutical Grade Sugammadex Sodium Product Portfolios and Specifications
13.26.3 ZHEJIANG AUSUN PHARMACEUTICAL CO LTD Pharmaceutical Grade Sugammadex Sodium Sales, Revenue, Price and Gross Margin (2018-2023)
13.26.4 ZHEJIANG AUSUN PHARMACEUTICAL CO LTD Main Business Overview
13.26.5 ZHEJIANG AUSUN PHARMACEUTICAL CO LTD Latest Developments
14 Research Findings and Conclusion
• 日本語訳：医薬品用スガマデクスナトリウムの世界市場2023-2029：純度≧99%、純度<99%
• レポートコード：MRCLP3DB5425 ▷ お問い合わせ（見積依頼・ご注文・質問）